The KOL presentation will review Arcturus’ interim clinical data from ARCT-810 Phase 2 trials evaluating the safety and pharmacodynamics of multiple doses of ARCT-810 in adolescent and adult ...

Victoria's Secret has restored all critical systems impacted by a May 24 security incident that forced it to shut down corporate systems and the e-commerce website.

Victoria's Secret did not provide many details about the security incident, or directly confirm whether it was a cyber or ransomware attack.

San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work in an effort to prioritize spending and extend its cash runway. | San ...

During the last three months, 7 analysts shared their evaluations of Arcturus Therapeutics ARCT, revealing diverse outlooks from bullish to bearish. The following table summarizes their recent ...

Victoria and David Beckham, who have been married for 25 years, have kids Brooklyn, Romeo, Cruz and Harper.

Arcturus says it’s “highly unlikely” it will lose funding for its bird flu trial, despite rumors swirling that Moderna’s support will be revoked.

Arcturus developed KOSTAIVE®, the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine in the world to be approved. Arcturus has an ongoing global collaboration for innovative mRNA vaccines ...

Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public skepticism. Click for my ARCT stock update.

Arcturus Therapeutics (ARCT) Holdings announced that the first CF and OTC deficiency participants initiated dosing in December 2024, in the company’s Phase 2 multiple ascending dose studies.